Early research (Phase 1)Study completedNCT04450004
What this trial is testing
Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.
Who this might be right for
SARS-CoV 2
Medicago 180
Showing 19 of 0 results